Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Les Laboratoires Servier
Les Laboratoires Servier_20100114
Les Laboratoires Servier_20131212
  

Les Laboratoires Servier patents

Recent patent applications related to Les Laboratoires Servier. Les Laboratoires Servier is listed as an Agent/Assignee. Note: Les Laboratoires Servier may have other listings under different names/spellings. We're not affiliated with Les Laboratoires Servier, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Les Laboratoires Servier-related inventors




Date Les Laboratoires Servier patents (updated weekly) - BOOKMARK this page
07/20/17 new patent  Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
06/22/17Monoclonal antibodies to progastrin and their uses
06/01/17Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
05/25/17Phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
05/18/17Isoquinoline compounds, a process for their preparation, and pharmaceutical compositions containing them
03/09/17Microsomes irreversibly inhibited for cyp450 their uses in the phenotyping of enzymatic metabolic pathways
02/23/17Salt of ivabradine and process for the preparation thereof
02/02/17Association between 8-cyclopropyl-3-[2-(3-fluorophenyl)ethyl]-7,8-dihydro-3h-[1,3]oxazino[6,5-g][1,2,3]benzotriazine-4,9-dione and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
02/02/17Association between 3-[(3--2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione and an egfr tyr kinase inhibitor
12/22/16Process for the synthesis of agomelatine
12/15/16Use of ivabradine as diagnostic agent in the coronary angiography by multislice computed tomography
07/07/16Isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them
06/23/16Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
06/16/16Forms of co-crystals of agomelatine and p toluenesulphonic acid, a process for their preparation and pharmaceutical compositions containing them
06/02/16Salt of 3-[(3--2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing i
06/02/16Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
02/25/16Use of 4-benzamide in the treatment of neuropathic pain
11/05/15Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
11/05/15Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
11/05/15Phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
09/03/15Syringe for obtaining nano-sized materials for selective assays and related methods of use
08/27/15Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it
06/25/15Thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them
03/19/15Association between 4-benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
03/19/15Association between 4-benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
03/19/15Combination of 4- benzamide and a nmda receptor antagonist and pharmaceutical compositions containing the same
02/19/15Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
02/05/15Association between n-hydroxy-4-benzamide and folfox
01/29/15Phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
01/29/15Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
12/25/14Agents for treating disorders involving modulation of ryanodine receptors
10/02/14Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine
09/04/14New salt of abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them
08/28/14Novel imaging agents, process for the preparation thereof and pharmaceutical compositions containing same
08/28/14Process for the enzymatic synthesis of (7s)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid and application in the synthesis of ivabradine and salts thereof
08/07/14Dividable galenical form allowing modified release of the active ingredient
06/12/14Process for the synthesis of 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
06/05/14Synthesis process, and crystalline form of 4-{3[cis-hexahydrocyclopent a[cjpyrrol-2( 1 h)-yljpropoxyj benzami de hydrochlori de and pharmaceutical compositions containing it
05/08/14Process for the synthesis of (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
05/01/14Process for preparing benzothiazepines from gamma-aminoalkylbenzenes
04/17/14Process for the synthesis of 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
04/10/14Synthesis process, and crystalline form of 4- benzamide hydrochloride and pharmaceutical compositions containing it
03/27/14Agents for treating disorders involving modulation of ryanodine receptors
01/09/14Crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same
12/12/13Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
10/31/13Process for the synthesis of agomelatine
10/31/13Process for the synthesis of agomelatine
10/24/13Agents for treating disorders involving modulation of ryanodine receptors
10/03/13Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
08/15/13Process for the enzymatic synthesis of (7s)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carboxylic acid or esters thereof, and application in the synthesis of ivabradine and salts thereof
08/15/13New process for the resolution of enantiomers of (3,4 dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitrile and application in the synthesis of ivabradine
08/08/13Pharmaceutical composition for the prolonged release of trimetazidine
08/08/13New process for the resolution of enantiomers of (3,4 dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl)nitrile and application in the synthesis of ivabradine
07/11/13Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it
07/11/13Process for the preparation of the l-arginine salt of perindopril
06/20/13Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
06/20/13Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
06/13/13Combination of 4-benzamide and a nmda receptor antagonist and pharmaceutical compositions containing the same
03/14/13Administration regime for n-hydroxy-4-benzamide
02/14/13Solid pharmaceutical composition for buccal administration of agomelatine
01/10/13Agomelatine hydrobromide hydrate and preparation thereof
01/03/13Agomelatine hydrochloride hydrate and preparation thereof
12/27/12Process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and application in the synthesis of agomelatine
12/13/12Synthesis process, and crystalline form of 4-benzamide hydrochloride and pharmaceutical compositions containing it
12/13/12Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing them
Patent Packs
12/06/12Use of agomelatine in obtaining medicaments intended for the treatment of obsessive-compulsive disorder (ocd)
11/08/12Association between 4-benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it
11/08/12Azabicyclo[3.1.0]hex-2-yl compounds, a process for their preparation and pharmaceutical compositions containing them
09/27/12Process for the synthesis of agomelatine
09/13/12Dihydro-oxazolobenzodiazepinone compounds, a process for there preparation and pharmaceutical compositions containing them
08/16/12Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
08/16/12Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
08/02/12Association of a sinus node if current inhibitor and an angiotensin converting enzyme inhibitor, and pharmaceutical compositions containing it
07/05/12Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
03/29/12Orodispersible pharmaceutical composition of perindopril
03/22/12Dihydrobenzoxathiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
02/23/12Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
02/02/12Process for the synthesis of strontium ranelate and its hydrates
12/15/11Use of the association of a sinus node if current inhibitor and an angiotensin-converting enzyme inhibitor in the treatment of heart failure
12/01/11Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
Patent Packs
11/24/11Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
09/22/11Association of a sinus node if current inhibitor and calcium inhibitor and pharmaceutical compositions containing it
08/18/11Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
06/09/11Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them
05/12/11Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them.
02/10/11Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
01/27/11Chromene compounds, a process for their preparationand pharmaceutical compositions containing them
12/16/10Polysubstituted pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamine compounds, a process for their preparation and pharmaceutical compositions containing them
11/11/10Diazeniumdiolate compounds, a process for their preparation and pharmaceutical compositions containing them.
10/21/10Orodispersible pharmaceutical composition of ivabradine
10/21/10Orodispersible pharmaceutical composition of perindopril
10/14/10Orodispersible pharmaceutical composition of agomelatine
09/30/10Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
09/30/10Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
09/23/10Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
08/12/10Indole compounds, a process for their preparation and pharmaceutical compositions containing them
08/05/10Method of screening compounds having anti-amyloid properties
07/08/10Process for preparing a solid pharmaceutical composition
07/01/10Camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them.
06/24/10Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
06/03/10Process for the synthesis of (methoxy-1-naphthyl) acetonitrile and application in the synthesis of agomelatine
05/13/10Use of ivabradine as diagonstic agent in the coronary angiography by multislice computed tomography
03/25/10Crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it
03/04/10Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
02/18/10Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
02/11/10Process for the synthesis of agomelatine
02/11/10Process for the synthesis of agomelatine
02/11/10Process for the synthesis of agomelatine
02/11/10Process for obtaining the crystalline form v of agomelatine
01/14/10Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them
Social Network Patent Pack
12/24/09Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
12/24/09Gamma-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
12/24/09Delta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
12/24/09Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
12/24/09Gamma d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
12/24/09Process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
12/17/09Azabicylic compounds, a process for their preparation and pharmaceutical compositions containing them
12/03/09Use of neuroprotective compounds in obtaining medicaments intended for the treatment of neurodegenerating diseases
11/05/09Heterocyclic oxime compounds, process for their preparation and pharmaceutical compositions containing them
10/01/09Diosmetin compounds, a process for their preparation and pharmaceutical composition containing them
Patent Packs
09/24/09Dividable galenical form allowing modified release of the active ingredient
09/24/09Heterocyclic cycloalkyl compounds, a process for their preparation and pharmaceutical compositions containing them
08/27/09Association of a sinus node if current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it
08/20/09Association of a sinus node if current inhibitor and a beta blocker
08/13/09Alpha crystalline form of the arginine salt of perindopril, a process for its preparation and pharmceutical compositions containing it.
07/23/09Beta crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it.
05/21/094-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds
05/21/09Process for the synthesis of (7-methoxy-1-naphthyl) acetonitrile and its application in the synthesis of agomelatine
05/14/09Heterocyclic oxime compounds a process for their preparation and pharmaceutical compositions containing them
03/26/09New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them
03/26/09Process for the synthesis of strontium ranelate and its hydrates
03/19/09Association between an anti-atherothrombotic and an angiotensin-converting enzyme inhibitor
03/19/09Piperazine compounds
03/19/09Piperazine compounds
03/12/091,2,4,5-tetrahydro-3h-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them
12/12/13Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
01/14/10Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Les Laboratoires Servier in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Les Laboratoires Servier with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';